Instil Bio Statistics
Total Valuation
Instil Bio has a market cap or net worth of $80.20 million. The enterprise value is $52.21 million.
Important Dates
The next estimated earnings date is Friday, May 9, 2025, before market open.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Instil Bio has 6.53 million shares outstanding. The number of shares has increased by 0.10% in one year.
Current Share Class | 6.53M |
Shares Outstanding | 6.53M |
Shares Change (YoY) | +0.10% |
Shares Change (QoQ) | +0.32% |
Owned by Insiders (%) | 9.16% |
Owned by Institutions (%) | 26.77% |
Float | 2.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.49 |
P/TBV Ratio | 0.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.76, with a Debt / Equity ratio of 0.51.
Current Ratio | 15.76 |
Quick Ratio | 14.35 |
Debt / Equity | 0.51 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.67 |
Financial Efficiency
Return on equity (ROE) is -37.51% and return on invested capital (ROIC) is -13.19%.
Return on Equity (ROE) | -37.51% |
Return on Assets (ROA) | -12.72% |
Return on Invested Capital (ROIC) | -13.19% |
Return on Capital Employed (ROCE) | -23.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -$5.30M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.94% in the last 52 weeks. The beta is 1.76, so Instil Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.76 |
52-Week Price Change | +15.94% |
50-Day Moving Average | 18.26 |
200-Day Moving Average | 24.66 |
Relative Strength Index (RSI) | 38.90 |
Average Volume (20 Days) | 158,278 |
Short Selling Information
The latest short interest is 549,304, so 8.42% of the outstanding shares have been sold short.
Short Interest | 549,304 |
Short Previous Month | 565,118 |
Short % of Shares Out | 8.42% |
Short % of Float | 24.12% |
Short Ratio (days to cover) | 6.64 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -59.96M |
Pretax Income | -123.32M |
Net Income | -74.14M |
EBITDA | -56.35M |
EBIT | -59.96M |
Earnings Per Share (EPS) | -$11.39 |
Full Income Statement Balance Sheet
The company has $113.32 million in cash and $86.89 million in debt, giving a net cash position of $26.43 million or $4.05 per share.
Cash & Cash Equivalents | 113.32M |
Total Debt | 86.89M |
Net Cash | 26.43M |
Net Cash Per Share | $4.05 |
Equity (Book Value) | 169.44M |
Book Value Per Share | 25.96 |
Working Capital | 116.57M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -55.70M |
Capital Expenditures | n/a |
Free Cash Flow | -55.70M |
FCF Per Share | -$8.53 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Instil Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.10% |
Shareholder Yield | -0.10% |
Earnings Yield | -94.28% |
FCF Yield | -70.83% |
Analyst Forecast
The average price target for Instil Bio is $114.00, which is 827.58% higher than the current price. The consensus rating is "Buy".
Price Target | $114.00 |
Price Target Difference | 827.58% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Dec 8, 2023 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |